There’s currently no reliable screening test for ovarian cancer, meaning that most cases are caught at an advanced stage, ...

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the ...

You might hear about your risk of ovarian cancer through an aunt, mother, sister or grandmother. For some, there are no signs of hereditary cancer in the family, but genetic testing still reveals a ...

Removing the fallopian tubes during routine gynecological surgery reduced the risk of serous ovarian cancer by nearly 80%.

A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian ...

Ovarian cancer spreads fast by recruiting the body’s own protective cells to clear the way—and that secret alliance may finally be its undoing.

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...

Sept. 12 -- FRIDAY, Sept. 11 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new test for women with pelvic tumors that are known to need surgery. The test, called OVA1, will ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Early menarche, late menopause, and long reproductive span increase ovarian cancer risk, particularly in postmenopausal women ...